BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12166078)

  • 1. [Internal quality control of cytology].
    Hirokawa M; Kanahara T
    Rinsho Byori; 2002 Jun; 50(6):591-4. PubMed ID: 12166078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality improvement in cytology: where do we go from here?
    Renshaw AA
    Arch Pathol Lab Med; 2011 Nov; 135(11):1387-90. PubMed ID: 22032562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control in cytopathology. A system for simultaneous monitoring of accuracy and education and for proficiency testing.
    Carney CN
    Acta Cytol; 1984; 28(5):535-40. PubMed ID: 6385591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canadian experience in cytology proficiency testing.
    Thompson DW
    Acta Cytol; 1989; 33(4):484-6. PubMed ID: 2546350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quality control of cytodiagnosis].
    Wakasa K
    Rinsho Byori; 2003 Mar; 51(3):257-60. PubMed ID: 12707999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cervical screening--its essence and quality-control methodology in cytology laboratories].
    Kostova P
    Akush Ginekol (Sofiia); 1998; 37(4):58-61. PubMed ID: 10360060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories.
    Wiener HG; Klinkhamer P; Schenck U; Arbyn M; Bulten J; Bergeron C; Herbert A
    Cytopathology; 2007 Apr; 18(2):67-78. PubMed ID: 17397490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forum on criteria for certification, licensure and quality control of cytology laboratories.
    Acta Cytol; 1971; 15(6):562-76. PubMed ID: 4944870
    [No Abstract]   [Full Text] [Related]  

  • 9. Intercollegiate report for cervical cytology laboratories.
    Cross P
    Cytopathology; 1997 Oct; 8(5):359-60. PubMed ID: 9313993
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytopathology in Germany.
    Schenck U
    Diagn Cytopathol; 2003 Feb; 28(2):112-3. PubMed ID: 12561036
    [No Abstract]   [Full Text] [Related]  

  • 11. Proficiency testing in cytology--does it have any value?
    Nagy GK; Collins DN; Newton LE
    Diagn Cytopathol; 1995 Jun; 12(4):381-3. PubMed ID: 7656763
    [No Abstract]   [Full Text] [Related]  

  • 12. The BSCC code of practice--exfoliative cytopathology (excluding gynaecological cytopathology).
    Chandra A; Cross P; Denton K; Giles T; Hemming D; Payne C; Wilson A; Wilson P
    Cytopathology; 2009 Aug; 20(4):211-23. PubMed ID: 19659955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Present situation and future prospects of the certification system for medical technologists--from the viewpoint of the Japanese Society of Clinical Cytology].
    Hatakeyama S; Hirooka Y
    Rinsho Byori; 2012 Jun; 60(6):580-4. PubMed ID: 22880238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology.
    Herbert A; Bergeron C; Wiener H; Schenck U; Klinkhamer P; Bulten J; Arbyn M
    Cytopathology; 2007 Aug; 18(4):213-9. PubMed ID: 17635161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality assurance measures in cytopathology.
    Wied GL
    Acta Cytol; 1988; 32(3):287. PubMed ID: 3287816
    [No Abstract]   [Full Text] [Related]  

  • 16. Crossing the quality chasm: a requirement for successful cervical cancer prevention in developing countries.
    Suba EJ
    Clin Lab Med; 2004 Dec; 24(4):945-63. PubMed ID: 15555750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytology proficiency testing has stumped experts.
    Voelker R
    JAMA; 1993 Dec; 270(23):2779, 2783. PubMed ID: 8133599
    [No Abstract]   [Full Text] [Related]  

  • 18. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
    Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
    Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening.
    Misra JS; Gupta HP; Das V
    Diagn Cytopathol; 2004 Dec; 31(6):376-9. PubMed ID: 15540174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replies to questions on Quality Assurance Measures in Cytopathology.
    Wied GL
    Acta Cytol; 1988; 32(6):913-39. PubMed ID: 3059737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.